The Norwegian cancer vaccine company has raised NOK 370 million and entered the Oslo Stock Exchange on Monday 3 June 2019.
Several interested parties have now become shareholders in the company, totalling approximately 1 500 shareholders, reports Oslo Cancer Cluster.
“It is good for the Norw